Head of Market Access, US

Your role

Orion is entering an exciting phase of growth in oncology and is seeking an accomplished, entrepreneurial Head of US Market Access to build and lead our US Market Access organization.
This unique opportunity will allow you to establish our US market access capability from the ground up and play a central role in preparing for the launch of innovative oncology medicines. As a strategic leader, you will define and execute market access strategies that enable patients to benefit from Orion's therapies while supporting sustainable, long-term business success.

Working closely both with lean, evolving US team and global leadership, you will lead efforts across payer strategy, pricing, reimbursement, contracting, trade and distribution, specialty pharmacy, patient services, and evidence-based access planning.

The position will report to VP Market Access & Information Services, Innovative Medicines.

Responsibilities

Build and Lead the Function
• Establish and lead Orion's US Market Access organization and capabilities in preparation for launch, including recruitment and development of a high-performing market access and payer field team
• Develop the strategy, operating model, governance and budget for US market access, to support future launches

Set the Access Strategy
• Lead and execute US payer, pricing and contracting strategy to maximize sustainable patient access and commercial value
• Provide US market access perspective into global pricing, asset strategy, portfolio decisions and Business Development assessments
• Anticipate payer, policy and reimbursement changes and translate them into strategic action

Drive Launch Readiness
• Build scalable market access infrastructure and lead trade and distribution strategy, specialty pharmacy planning, and patient support strategy
• Drive cross-functional access readiness

Deliver Value to Payers and Patients
• Lead US payer engagement strategy, value proposition development, and payer-facing tools to optimize coverage and reimbursement.
• Shape evidence-generation priorities and contribute to HEOR and RWE evidence strategy and execution

What you can expect from us

At Orion, we are committed to bringing innovative therapies to patients with significant unmet medical needs. This role offers a rare opportunity to influence both strategy and execution at a pivotal moment in our oncology growth journey.

You will have the chance to:
• Build a US Market Access organization from the ground up
• Shape access strategy for future oncology launches
• Influence enterprise-wide decisions and commercial strategy
• Work closely with global and US leadership teams
• Make a meaningful impact on patient access to innovative medicines

Please visit our website to find further information about our values and Orion as an employer https://www.orion.fi/en/careers/orion-as-an-employer/.

If you are a strategic market access leader with a passion for building organizations and launching innovative oncology therapies, we invite you to join Orion and help shape the future of cancer care.

What are we looking for?

• Bachelor’s degree required. Advanced degree preferred (e.g., MBA, MPH, PharmD, MSc, or other relevant graduate degree)
• 10+ years of US pharmaceutical market access experience
• Strong understanding of US healthcare stakeholders, payer systems, and access landscape
• Demonstrated success leading market access planning and execution for pre-launch and launch products in oncology. Rare oncology experience is strongly preferred
• Deep expertise in payer strategy, pricing, reimbursement, trade/channel strategy and organizing patient support services
• Proven ability to build teams and capabilities from the ground up
• Strong strategic mindset combined with a hands-on, execution-focused approach
• Experience leading within complex, cross-functional, matrix environments
• Outstanding communication, influencing, and stakeholder management skills
• Entrepreneurial and comfortable operating in a dynamic growth environment
• Passionate about improving patient access to innovative medicines
• Collaborative, resilient, and results oriented
• Able to balance strategic thinking with operational execution

How to apply

• We invite you to send your application as soon as possible, no later than Wednesday November 11, 2026.
• We typically review applications already during the application period and may start interviewing candidates before the application deadline
• For additional information please contact Marjo Apajasalo, VP Market Access & Information Services iMeds, tel. +358 50 966 4143, on November 2 at 8-9 EDT or November 4 at 8-9 EDT.

Your new team

The Innovative Medicines business division is responsible for the strategic leadership of Orion’s business in core therapy areas, Pain and Oncology, covering all activities from pipeline and portfolio building to commercialization. Innovative Medicines Business Division, where patients’ unmet needs meet innovation, bringing new treatments to promote health and well-being in society.

Orion’s pharmaceutical innovations are created within its R&D organization. We employ top professionals in the field of drug discovery and development. We work globally: in Espoo and Turku in Finland, in Cambridge and Nottingham in England and in Cambridge, USA. Orion R&D and the Innovative Medicines business division are dedicated to becoming a global player in oncology and pain therapy areas.